UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites

Ubiquitination is a post-translational modification (PTM) that is essential for balancing numerous physiological processes. To enable delineation of protein ubiquitination at a site-specific level, we generated an antibody, denoted UbiSite, recognizing the C-terminal 13 amino acids of ubiquitin, which remain attached to modified peptides after proteolytic digestion with the endoproteinase LysC. Notably, UbiSite is specific to ubiquitin. Furthermore, besides ubiquitination on lysine residues, protein N-terminal ubiquitination is readily detected as well. By combining UbiSite enrichment with sequential LysC and trypsin digestion and high-accuracy MS, we identified over 63,000 unique ubiquitination sites on 9,200 proteins in two human cell lines. In addition to uncovering widespread involvement of this PTM in all cellular aspects, the analyses reveal an inverse association between protein N-terminal ubiquitination and acetylation, as well as a complete lack of correlation between changes in protein abundance and alterations in ubiquitination sites upon proteasome inhibition.Using UbiSite, an antibody-based approach that specifically detects protein lysine and N-terminal ubiquitination, Blagoev and colleagues uncover lack of correlation between changes in protein ubiquitination and abundance upon proteasome inhibition.

[1]  D R Mani,et al.  Refined Preparation and Use of Anti-diglycine Remnant (K-ε-GG) Antibody Enables Routine Quantification of 10,000s of Ubiquitination Sites in Single Proteomics Experiments* , 2012, Molecular & Cellular Proteomics.

[2]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[3]  Kristoffer T G Rigbolt,et al.  Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking , 2016, Nature Structural &Molecular Biology.

[4]  P. Thibault,et al.  N-Terminal Ubiquitination of Extracellular Signal-Regulated Kinase 3 and p21 Directs Their Degradation by the Proteasome , 2004, Molecular and Cellular Biology.

[5]  B. Blagoev,et al.  Cylindromatosis Tumor Suppressor Protein (CYLD) Deubiquitinase is Necessary for Proper Ubiquitination and Degradation of the Epidermal Growth Factor Receptor* , 2017, Molecular & Cellular Proteomics.

[6]  David Baker,et al.  Intrinsic disorder drives N-terminal ubiquitination by Ube2w , 2014, Nature chemical biology.

[7]  V. Lang,et al.  Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin‐binding entities , 2009, EMBO reports.

[8]  A. Ciechanover,et al.  N-terminal ubiquitination: more protein substrates join in. , 2004, Trends in cell biology.

[9]  Jennifer E. Gilda,et al.  Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS) , 2015, PloS one.

[10]  Yanji Xu,et al.  Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. , 2012, Journal of proteome research.

[11]  John Rush,et al.  Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation , 2009, Cell.

[12]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[13]  M. Kirschner,et al.  Substrate degradation by the proteasome: A single-molecule kinetic analysis , 2015, Science.

[14]  T. Arnesen,et al.  The world of protein acetylation. , 2016, Biochimica et biophysica acta.

[15]  Soichi Wakatsuki,et al.  Ubiquitin-binding domains — from structures to functions , 2009, Nature Reviews Molecular Cell Biology.

[16]  M. Mann,et al.  Status of Large-scale Analysis of Post-translational Modifications by Mass Spectrometry* , 2013, Molecular & Cellular Proteomics.

[17]  B. Blagoev,et al.  Characterization of ubiquitination dependent dynamics in growth factor receptor signaling by quantitative proteomics. , 2011, Molecular bioSystems.

[18]  L. Jensen,et al.  Mass Spectrometric Analysis of Lysine Ubiquitylation Reveals Promiscuity at Site Level* , 2010, Molecular & Cellular Proteomics.

[19]  Aaron Ciechanover,et al.  The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.

[20]  Sebastian A. Wagner,et al.  A Proteome-wide, Quantitative Survey of In Vivo Ubiquitylation Sites Reveals Widespread Regulatory Roles* , 2011, Molecular & Cellular Proteomics.

[21]  Karina D. Sørensen,et al.  An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes , 2017, Cell systems.

[22]  Kristoffer T G Rigbolt,et al.  Inactivation of effector caspases through nondegradative polyubiquitylation. , 2008, Molecular cell.

[23]  Sebastian A. Wagner,et al.  Regulation of ubiquitin-binding proteins by monoubiquitination , 2006, Nature Cell Biology.

[24]  J. Olsen,et al.  Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. , 2014, Journal of proteome research.

[25]  P. Sharp,et al.  Cre-lox-regulated conditional RNA interference from transgenes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Kristoffer T G Rigbolt,et al.  GProX, a User-Friendly Platform for Bioinformatics Analysis and Visualization of Quantitative Proteomics Data* , 2011, Molecular & Cellular Proteomics.

[27]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2009 update , 2009, Nucleic Acids Res..

[28]  A. Taylor Aminopeptidases: structure and function , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Blagoy Blagoev,et al.  StUbEx PLUS-A Modified Stable Tagged Ubiquitin Exchange System for Peptide Level Purification and In-Depth Mapping of Ubiquitination Sites. , 2018, Journal of proteome research.

[30]  A. Ciechanover,et al.  A novel site for ubiquitination: the N‐terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein , 1998, The EMBO journal.

[31]  M. Maldonado,et al.  The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. , 2006, Cellular & molecular immunology.

[32]  E. Gelmann,et al.  The ubiquitin-proteasome pathway and its role in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Sheridan Drug makers target ubiquitin proteasome pathway anew , 2015, Nature Biotechnology.

[34]  Jacob D. Jaffe,et al.  Methods for Quantification of in vivo Changes in Protein Ubiquitination following Proteasome and Deubiquitinase Inhibition* , 2012, Molecular & Cellular Proteomics.

[35]  F. Cecconi,et al.  AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics. , 2014, Developmental cell.

[36]  F. Poulsen,et al.  Using guanidine-hydrochloride for fast and efficient protein digestion and single-step affinity-purification mass spectrometry. , 2013, Journal of proteome research.

[37]  William S. Hlavacek,et al.  Phosphorylation Site Dynamics of Early T-cell Receptor Signaling , 2014, PloS one.

[38]  Edward L. Huttlin,et al.  Systematic and quantitative assessment of the ubiquitin-modified proteome. , 2011, Molecular cell.

[39]  B. Blagoev,et al.  Quantitative phosphoproteomics to characterize signaling networks. , 2012, Seminars in cell & developmental biology.

[40]  Jesper V Olsen,et al.  Performance Evaluation of the Q Exactive HF-X for Shotgun Proteomics. , 2018, Journal of proteome research.

[41]  Pier Paolo Pandolfi,et al.  The mechanisms of PML-nuclear body formation. , 2006, Molecular cell.

[42]  Pier Paolo Di Fiore,et al.  Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation , 2003, Nature Cell Biology.

[43]  Hai-bo Xiao,et al.  The role of the ubiquitin-proteasome pathway in cancer development and treatment. , 2014, Frontiers in bioscience.

[44]  S. Jentsch,et al.  Protein Group Modification and Synergy in the SUMO Pathway as Exemplified in DNA Repair , 2012, Cell.

[45]  L. Dick,et al.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.

[46]  S. Linder,et al.  Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition , 2017, Oncotarget.

[47]  Steven P Gygi,et al.  A proteomics approach to understanding protein ubiquitination , 2003, Nature Biotechnology.

[48]  Xuejun Jiang,et al.  Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. , 2006, Molecular cell.

[49]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[50]  H. Kowarzyk Structure and Function. , 1910, Nature.

[51]  S. Gygi,et al.  Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. , 2016, Cell systems.

[52]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[53]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[54]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[55]  Chunaram Choudhary,et al.  Proteomic Analyses Reveal Divergent Ubiquitylation Site Patterns in Murine Tissues* , 2012, Molecular & Cellular Proteomics.

[56]  Linda Hicke,et al.  Ubiquitin-binding domains , 2005, Nature Reviews Molecular Cell Biology.

[57]  K. Bezstarosti,et al.  Quantitative Proteomics Reveals Extensive Changes in the Ubiquitinome after Perturbation of the Proteasome by Targeted dsRNA-Mediated Subunit Knockdown in Drosophila. , 2017, Journal of proteome research.

[58]  M. Pagano,et al.  Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation , 2003, Cell.

[59]  B. Maček,et al.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis , 2011, Nature.

[60]  John Rush,et al.  Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[61]  S. Linder,et al.  Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress. , 2014, Antioxidants & redox signaling.

[62]  H. Paulson,et al.  Ubiquitin pathways in neurodegenerative disease , 2014, Front. Mol. Neurosci..

[63]  K. Chi Drug developers delve into the cell's trash-disposal machinery , 2016, Nature Reviews Drug Discovery.

[64]  Samie R Jaffrey,et al.  Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling , 2010, Nature Biotechnology.

[65]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[66]  Boris Macek,et al.  Internally tagged ubiquitin: a tool to identify linear polyubiquitin-modified proteins by mass spectrometry , 2017, Nature Methods.

[67]  M. L. Nielsen,et al.  Advances in characterizing ubiquitylation sites by mass spectrometry. , 2013, Current opinion in chemical biology.

[68]  D. McConkey,et al.  Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. , 2005, Cancer research.

[69]  Kristoffer T G Rigbolt,et al.  StUbEx: Stable tagged ubiquitin exchange system for the global investigation of cellular ubiquitination. , 2012, Journal of proteome research.

[70]  K. Gevaert,et al.  Improved visualization of protein consensus sequences by iceLogo , 2009, Nature Methods.

[71]  Mårten Fryknäs,et al.  Inhibition of proteasome deubiquitinating activity as a new cancer therapy , 2011, Nature Medicine.

[72]  Jesper V Olsen,et al.  Rapid and deep proteomes by faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap mass spectrometer. , 2014, Journal of proteome research.

[73]  N. Mailand,et al.  Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers , 2016, Nature Reviews Molecular Cell Biology.